Thomas W. Beetham serves as Executive at Kiniksa Pharmaceuticals, Ltd., where they oversee executive responsibilities. Since joining the company, Thomas W. Beetham has executed 16 insider transactions totaling $2.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 27, 2024 involved purchasing 5,000 shares valued at $117.0K.
Thomas W. Beetham currently holds 6,000 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas W. Beetham has been a net seller of KNSA stock. They have purchased $117.0K and sold $2.1M worth of shares.
Thomas W. Beetham's most recent insider trade was on Sep 27, 2024, when they purchased 5,000 shares at $23.41 per share.
Get notified when new Form 4 filings are submitted
| $0.94 |
| Discretionary |
| May 31, 2022 | MGTA | $3.0K | Award | 3,000 | $0.99 | Discretionary |
| Sep 16, 2021 | MGTA | $41.1K | Sale | 6,103 | $6.73 | Discretionary |
| Sep 14, 2021 | MGTA | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 3, 2021 | KNSA | $0 | Conversion | 300,000 | $N/A | Discretionary |
| Feb 3, 2021 | KNSA | $54.7K | Sale | 2,477 | $22.09 | Discretionary |
| Jul 1, 2020 | KNSA | $676.9K | Sale | 26,734 | $25.32 | Discretionary |
| Jul 1, 2020 | KNSA | $73.8K | Sale | 2,855 | $25.84 | Discretionary |
| Jun 10, 2020 | KNSA | $21.9K | Option Exercise | 13,752 | $1.59 | Discretionary |
| Jun 10, 2020 | KNSA | $344.8K | Sale | 13,752 | $25.07 | Discretionary |
| Apr 21, 2020 | KNSA | $19.5K | Sale | 955 | $20.44 | Discretionary |
| Apr 21, 2020 | KNSA | $30.6K | Sale | 1,563 | $19.56 | Discretionary |
| Apr 20, 2020 | KNSA | $903.9K | Sale | 47,423 | $19.06 | Discretionary |
| Feb 14, 2020 | KNSA | $1.1K | Sale | 59 | $18.58 | Discretionary |
| May 29, 2018 | KNSA | $0 | Conversion | 6,392 | $N/A | Discretionary |